Sumit Sharma retweeted
Performance of GPT-5 Frontier Models in Ophthalmology Question Answering ow.ly/8QLe50XHpu9 @FaresAntaki @DavidMikhail01 @DanielMiladMD @SumitSharmaMD @pearsekeane, @YihTham @Renaudduval1 #ophthalmology
3
1
6
747
Hemorrhagic Occlusive Retinal Vasculitis in a Pregnant Woman ow.ly/PFbQ50SbGih @SumitSharmaMD #ophthalmology #retina
7
18
960
Earn No-Fee #CME Credit Today! Earn up to 4.25 Credits! Into the Suprachoroidal Space: The Next Frontier in Treatment of Posterior Segment Eye Disease View here: evolvemeded.com/course-group…
1
191
Biosimilars are here. Please join us if you’d like to learn more. #retina @MayoClinicEye @SumitSharmaMD @EvolveMedEd
New #CME Curriculum, including a supplement and a webinar, available NOW: “Making the Cut: What You Need to Know About Biosimilars for Retinal Diseases.” View more here: bit.ly/3MIJG5C
2
1
3
1,076
Join Drs. Srivastava and @SumitSharmaMD for this Live-Virtual #CME Symposium as they discuss the suprachoroidal space as a prospective pathway for novel drug delivery systems to treat posterior segment eye diseases! Save your spot today: evolvemeded.com/webinars/222…
1
180
#Biosimilars are a Trending Topic! We Have the Info You Need! View more here: evolvemeded.com/course-group…
1
2
210
Sumit Sharma retweeted
Discover how the sustained delivery of corticosteroids can improve post-surgical outcomes in patients undergoing retinal surgery with experts @sumitsharmamd & @drrishisingh in this curbside consult >> ow.ly/JFgZ50HccIa
[NEW] CME Webinar - Understanding the Signs: Mastering Uveitis Diagnosis and Treatment Strategies w/ Drs. @SumitSharmaMD and Steven Yeh, MD View more here: evolvemeded.com/course/2237-…
Starting soon! Virtual CME Symposium: Understanding the Signs: Mastering Uveitis Diagnosis and Treatment Strategies view here: evolvemeded.com/course/2237-…
Join Drs. Srivastava, Sharma, and Yeh for a CME Symposium live at RPM Events in Chicago. Approved for AMA PRA Category 1 Credit™. Save your spot here: bit.ly/3wV4mii
2
3
Join Retina Specialists @SumitSharmaMD, and Steven Yeh, MD for a Virtual CME Symposium on Wednesday, September 14! View More Here: evolvemeded.com/webinars/223…
1
1
I really like this vision review and wish I could thank the creator as it’s so well done.
6
359
16
1,700
Join Us for a CME Dinner Symposium in Chicago or Online! "Into the Suprachoroidal Space: The Next Frontier in Treatment of Posterior Segment Eye Disease" w/ Drs. @SumitSharmaMD, Sunil K. Srivastava, & Steven Yeh Register here: evolvemeded.com/course/2228_…
1
2
Earn free #CME and learn from experts, @sumitsharmamd & @drrishisingh >> ow.ly/JFgZ50HccIa
1
2
Assess how the sustained delivery of corticosteroids can improve post-surgical outcomes in patients undergoing retinal surgery with experts @sumitsharmamd & Dilraj S. Grewal, MD, FASRS in this #CME curbside consult >> ow.ly/yLiW50HccAK
1
1
In this newly posted Curbside Consults activity, experts @sumitsharmamd & Dilraj S. Grewal, MD, FASRS evaluate the spectrum of posterior uveitis >> ow.ly/fVoR50HccMu
1
1
A new tool for quantifying inflammation associated with uveitis may predict outcomes for patients. Cindy Chen, BA, of the Cole Eye Institute @ClevelandClinic, explains more. #Ophthalmology #Ocular #VisualAcuity #Imaging buff.ly/3CJsgyo
3
4
Case Western Reserve University and Cleveland Clinic to host first presidential debate on September 29 wkyc.com/mobile/article/news… via @wkyc
1
1
Sumit Sharma retweeted
Watch now ▶️ Evaluate new technology & techniques used to improve outcomes in patients undergoing vitreoretinal surgery in this #FreeCME activity --> ow.ly/epAi50zq89W @drrishisingh , @Amoshfeghi, @sophieb2020 , @sumitsharmamd
1
5
This is different than in conditions where uveitis is not a feature: ETA was associated with de novo uveitis more Than TNF inhib mAbs #uveitis @sumitsharmamd @drjoshhedrick
French retrospective study of 429 pts (302 SpA, 127 PsA) compared 203 on TNF inhib mAb vs 226 on etandercept as 1st TNFi. The probability of uveitis during the 1st yr was lower with ETA but not signif different than mAbs (OR 0.94; 0.35; 2.54) bit.ly/2xTz7cg
3
8